Rosuvastatin inhibit ox-LDL-induced platelet activation by the p38/MAPK pathway
Our study revealed the rosuvastatin could inhibit the aggregation, adhesion and activation of platelet induced by ox-LDL, its mechanism may be related to inhibition of p38/MAPK signal pathway.
Authors
- Wei Jiao
- Yanan Xie (ORCID: https://orcid.org/0000-0001-6324-6030)
- Mingjie Meng
- Jinming Liu (ORCID: https://orcid.org/0000-0001-6835-9982)
- Fang Li (ORCID: https://orcid.org/0009-0003-2442-6604)
- Jie Hao (ORCID: https://orcid.org/0000-0002-0273-8047)
Institutions
- Hebei Medical University (CN)
- Second Hospital of Hebei Medical University (CN)
Publication Details
- Journal
- Clinical Hemorheology and Microcirculation
- Published
- 2024-09-13
- DOI
- https://doi.org/10.3233/ch-242359
- Citations
- 3
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.21